Literature DB >> 19366839

Oncology clinicians' accounts of discussing complementary and alternative medicine with their patients.

Alex Broom1, Jon Adams.   

Abstract

The profile of complementary and alternative medicine (CAM) has risen dramatically over recent years, with cancer patients representing some of the highest users of any patient group. This article reports the results from a series of in-depth interviews with oncology consultants and oncology nurses in two hospitals in Australia. Analysis identifies a range of self-reported approaches with which oncology clinicians discuss CAM, highlighting the potential implications for patient care and inter-professional dynamics. The interview data suggest that, whilst there are a range of consultant approaches to CAM, ;risk' is consistently deployed rhetorically as a key regulatory strategy to frame CAM issues and potentially direct patient behaviour. Moreover, ;irrationality', ;seeking control', and ;desperation' were viewed by consultants as the main drivers of CAM use, presenting potential difficulties for effective doctor-patient dialogue about CAM. In contrast, oncology nurses appear to perceive their role as that of CAM and patient advocate - an approach disapproved of by the consultants on their respective teams, presenting implications for oncology teamwork. CAM education emerged as a contentious and crucial issue for oncology clinicians. Yet, while viewed as a key barrier to clinician-patient communication about CAM, various forms of individual and organizational resistance to CAM education were evident. A number of core issues for clinical practice and broader work in the sociology of CAM are discussed in light of these findings.

Entities:  

Mesh:

Year:  2009        PMID: 19366839     DOI: 10.1177/1363459308101806

Source DB:  PubMed          Journal:  Health (London)        ISSN: 1363-4593


  17 in total

1.  Let's Talk About Those Herbs You Are Taking: Ethical Considerations for Communication With Patients With Cancer About Complementary and Alternative Medicine.

Authors:  Laura Tenner; Fay J Hlubocky; Charles D Blanke; Thomas W LeBlanc; Jonathan M Marron; Molly M McGinnis; Rebecca A Spence; Lynne P Taylor
Journal:  J Oncol Pract       Date:  2019-01       Impact factor: 3.840

2.  A pre-post evaluation of oncology healthcare providers' knowledge, attitudes, and practices following the implementation of a complementary medicine practice guideline.

Authors:  Emilie N Hayward; Cody Z Watling; Lynda G Balneaves
Journal:  Support Care Cancer       Date:  2021-06-07       Impact factor: 3.603

Review 3.  Effective communication about the use of complementary and integrative medicine in cancer care.

Authors:  Moshe Frenkel; Lorenzo Cohen
Journal:  J Altern Complement Med       Date:  2013-07-17       Impact factor: 2.579

4.  Convergent priorities and tensions: a qualitative study of the integration of complementary and alternative therapies with conventional cancer treatment.

Authors:  Jo River; Heather McKenzie; David Levy; Nick Pavlakis; Michael Back; Byeongsang Oh
Journal:  Support Care Cancer       Date:  2017-12-16       Impact factor: 3.603

5.  Oncologists' experiences of discussing complementary and alternative treatment options with their cancer patients. A qualitative analysis.

Authors:  Güthlin Corina; Holmberg Christine; Gudrun Klein
Journal:  Support Care Cancer       Date:  2016-04-14       Impact factor: 3.603

Review 6.  Addressing Complementary and Alternative Medicine Use Among Individuals With Cancer: An Integrative Review and Clinical Practice Guideline.

Authors:  Lynda G Balneaves; Cody Z Watling; Emilie N Hayward; Brenda Ross; Jill Taylor-Brown; Antony Porcino; Tracy L O Truant
Journal:  J Natl Cancer Inst       Date:  2022-01-11       Impact factor: 13.506

7.  Complementary and alternative medicine use by glioma patients in Switzerland.

Authors:  Günter Eisele; Ulrich Roelcke; Katrin Conen; Fabienne Huber; Tobias Weiss; Silvia Hofer; Oliver Heese; Manfred Westphal; Caroline Hertler; Patrick Roth; Michael Weller
Journal:  Neurooncol Pract       Date:  2018-10-12

8.  {Omega}-3 fatty acid supplement use in the 45 and Up Study Cohort.

Authors:  Jon Adams; David Sibbritt; Chi-Wai Lui; Alex Broom; Jonathan Wardle
Journal:  BMJ Open       Date:  2013-04-11       Impact factor: 2.692

9.  A Qualitative Investigation of Health Care Professionals', Patients' and Partners' Views on Psychosocial Issues and Related Interventions for Couples Coping with Cancer.

Authors:  Tim Regan; Janelle V Levesque; Sylvie D Lambert; Brian Kelly
Journal:  PLoS One       Date:  2015-07-29       Impact factor: 3.240

10.  Positive patient experiences in an Australian integrative oncology centre.

Authors:  Bonnie J Furzer; Anna S Petterson; Kemi E Wright; Karen E Wallman; Timothy R Ackland; David J L Joske
Journal:  BMC Complement Altern Med       Date:  2014-05-14       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.